208 related articles for article (PubMed ID: 12110335)
21. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
[TBL] [Abstract][Full Text] [Related]
22. Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels.
Tsai CH; Yang SF; Chen YJ; Chu SC; Hsieh YS; Chang YC
Oral Dis; 2004 Nov; 10(6):360-4. PubMed ID: 15533212
[TBL] [Abstract][Full Text] [Related]
23. In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids.
Chen CC; Huang JF; Tsai CC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Nov; 11(11):604-14. PubMed ID: 7490793
[TBL] [Abstract][Full Text] [Related]
24. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
25. Arecoline inhibits epithelial cell viability by upregulating the apoptosis pathway: implication for oral submucous fibrosis.
Li M; Gao F; Zhou ZS; Zhang HM; Zhang R; Wu YF; Bai MH; Li JJ; Lin SR; Peng JY
Oncol Rep; 2014 May; 31(5):2422-8. PubMed ID: 24647969
[TBL] [Abstract][Full Text] [Related]
26. The upregulation of insulin-like growth factor-1 in oral submucous fibrosis.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
Oral Oncol; 2005 Oct; 41(9):940-6. PubMed ID: 16054426
[TBL] [Abstract][Full Text] [Related]
27. STRO-1 confers myofibroblast transdifferentiation in fibroblasts derived from oral submucous fibrosis.
Yu CC; Liao YW; Yu CH; Chang YC
J Oral Pathol Med; 2018 Mar; 47(3):299-305. PubMed ID: 29210111
[TBL] [Abstract][Full Text] [Related]
28. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
29. Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
Hsieh YP; Wu KJ; Chen HM; Deng YT
J Formos Med Assoc; 2018 Jun; 117(6):527-534. PubMed ID: 28720506
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma.
Yang JS; Chen MK; Yang SF; Chang YC; Su SC; Chiou HL; Chien MH; Lin CW
Clin Chem Lab Med; 2014 Sep; 52(9):1367-77. PubMed ID: 24695043
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids.
Harvey W; Scutt A; Meghji S; Canniff JP
Arch Oral Biol; 1986; 31(1):45-9. PubMed ID: 3458437
[TBL] [Abstract][Full Text] [Related]
32. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.
Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021
[TBL] [Abstract][Full Text] [Related]
33. Growth of oral and skin fibroblasts from patients with oral submucous fibrosis.
van Wyk CW; Olivier A; Hoal-van Helden EG; Grobler-Rabie AF
J Oral Pathol Med; 1995 Sep; 24(8):349-53. PubMed ID: 7500290
[TBL] [Abstract][Full Text] [Related]
34. E3 ligase carboxyl-terminus of Hsp70-interacting protein (CHIP) suppresses fibrotic properties in oral mucosa.
Chen SC; Liu CM; Hsieh PL; Liao YW; Lin YJ; Yu CC; Yu CH
J Formos Med Assoc; 2020 Feb; 119(2):595-600. PubMed ID: 31653576
[TBL] [Abstract][Full Text] [Related]
35. Elevated expression of NF-kappaB in oral submucous fibrosis--evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts.
Ni WF; Tsai CH; Yang SF; Chang YC
Oral Oncol; 2007 Jul; 43(6):557-62. PubMed ID: 16996785
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro.
Chang YC; Tai KW; Cheng MH; Chou LS; Chou MY
J Oral Pathol Med; 1998 Feb; 27(2):68-71. PubMed ID: 9526732
[TBL] [Abstract][Full Text] [Related]
37. The expression of O(6) -methylguanine-DNA methyltransferase in human oral keratinocytes stimulated with arecoline.
Lee SS; Tsai CH; Yu CC; Ho YC; Hsu HI; Chang YC
J Oral Pathol Med; 2013 Sep; 42(8):600-5. PubMed ID: 23278137
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of GMI, an immunomodulatory protein from Ganoderma microsporum, on myofibroblast activity and proinflammatory cytokines in human fibrotic buccal mucosal fibroblasts.
Lee PH; Hsieh PL; Liao YW; Yu CC
Environ Toxicol; 2018 Jan; 33(1):32-40. PubMed ID: 28984080
[TBL] [Abstract][Full Text] [Related]
39. Regulation of extracellular matrix genes by arecoline in primary gingival fibroblasts requires epithelial factors.
Thangjam GS; Agarwal P; Balapure AK; Rao SG; Kondaiah P
J Periodontal Res; 2009 Dec; 44(6):736-43. PubMed ID: 19438976
[TBL] [Abstract][Full Text] [Related]
40. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis.
Tsai CC; Ma RH; Shieh TY
J Oral Pathol Med; 1999 Feb; 28(2):59-63. PubMed ID: 9950251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]